ScienceDaily (Mar. 4, 2010) Researchers have demonstrated the safety of a potential vaccine against mesothelioma, a rare cancer associated primarily with asbestos exposure. The vaccine, which infuses a patient's own dendritic cells (DC) with antigen from the patient's tumor, was able to induce a T-cell response against mesothelioma tumors.
See Also:Health & MedicineMesotheliomaDiseases and ConditionsCancerBrain TumorToday's HealthcareVaccinesReferenceTumor suppressor geneMesotheliomaMetastasisTumor
"
View the
Original article
No comments:
Post a Comment